Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/ABBI.1999.1355PMID 10496978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: correlation with DNA topoisomerase II-alpha and p53 expression.

  1999cited by this paper
• Effects of camptothecin analogues on DNA transformations mediated by calf thymus and human DNA topoisomerases I.

  1998cited by this paper
• Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.

  1998cited by this paper
• Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.

  1998cited by this paper
• Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I*

  1998cited by this paper
• Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.

  1998cited by this paper
• Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities.

  1998cited by this paper
• Novel 7-alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified mammalian topoisomerase I and in human colon carcinoma SW620 cells.

  1997cited by this paper
• Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma.

  1997cited by this paper
• Processing of topoisomerase I cleavable complexes into DNA damage by transcription.

  1997cited by this paper
• Human deoxyribonucleic acid topoisomerases: molecular targets of anticancer drugs.

  1997cited by this paper
• 9‐aminocamptothecin by 72‐hour continuous intravenous infusion is Inactive in the treatment of patients with 5‐fluorouracil‐refractory colorectal carcinoma

  1997cited by this paper
• Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.

  1997cited by this paper
• Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer.

  1996cited by this paper
• Purification of DNA topoisomerase I from the spleen of a patient with non-Hodgkin's lymphoma.

  1996cited by this paper
• Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.

  1996cited by this paper
• Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies.

  1996cited by this paper
• DNA topoisomerases.

  1996cited by this paper
• Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.

  1995cited by this paper
• Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.

  1995cited by this paper
• Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.

  1995cited by this paper
• Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.

  1993cited by this paper
• Inhibitors of DNA topoisomerase I isolated from the roots of Zanthoxylum nitidum

  1993cited by this paper
• Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin.

  1991cited by this paper
• New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.

  1991cited by this paper
• DNA topoisomerase I from human placenta.

  1990cited by this paper
• Human DNA topoisomerase II: evaluation of enzyme activity in normal and neoplastic tissues.

  1990cited by this paper
• DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.

  1989cited by this paper
• Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity.

  1989cited by this paper
• Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.

  1989cited by this paper
• Plant antitumor agents, 27. Isolation, structure, and structure activity relationships of alkaloids from Fagara macrophylla.

  1987cited by this paper
• Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

  1985cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Synthetic Lethal Activity of Benzophenanthridine Alkaloids From Zanthoxylum coco Against BRCA1-Deficient Cancer Cells

  2020cites this paper
• Isolation, Synthesis and Medicinal Significance of Marine Pyridoacridine Alkaloids

  2019cites this paper
• Activity of Topotecan toward the DNA/Topoisomerase I Complex: A Theoretical Rationalization.

  2018cites this paper
• Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.

  2018cites this paper
• Tumor-Selective Cytotoxicity of Nitidine Results from Its Rapid Accumulation into Mitochondria

  2017influential citation
• Novel securinine derivatives as topoisomerase I based antitumor agents.

  2016cites this paper
• Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride

  2016cites this paper
• A Novel Inhibitor of Topoisomerase I Is Selectively Toxic for a Subset of Non–Small Cell Lung Cancer Cell Lines

  2015cites this paper
• Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-phenanthroline derivatives

  2015cites this paper
• The Contribution of Human OCT1, OCT3, and CYP3A4 to Nitidine Chloride–Induced Hepatocellular Toxicity

  2014cites this paper
• The effect of nitidine chloride on the proliferation and apoptosis of nasopharyngeal carcinoma cells.

  2014cites this paper
• Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.

  2013cites this paper
• PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67

  2013cites this paper
• Stress response to genotoxic agents and to infection

  2012cites this paper
• Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex.

  2012cites this paper
• Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kappaB pathway in RAW 264.7 cells.

  2012cites this paper
• Targeting DNA topoisomerase I with non-camptothecin poisons.

  2012cites this paper
• Cloning and biochemical characterization of Staphylococcus aureus type IA DNA topoisomerase comprised of distinct five domains.

  2011cites this paper
• Down-regulation of lipids transporter ABCA1 increases the cytotoxicity of Nitidine

  2010cites this paper
• Biophysical aspects and biological implications of the interaction of benzophenanthridine alkaloids with DNA

  2009cites this paper
• An endophytic fungus from Camptotheca acuminata that produces camptothecin and analogues.

  2009cites this paper
• Persistence of camptothecin analog-topoisomerase I-DNA ternary complexes: a molecular dynamics study.

  2008cites this paper
• Topoisomerase I-mediated DNA cleavage induced by the minor groove-directed binding of bibenzimidazoles to a distal site.

  2007cites this paper
• Molecular modes of action of cytotoxic alkaloids: from DNA intercalation, spindle poisoning, topoisomerase inhibition to apoptosis and multiple drug resistance.

  2007cites this paper
• Review camptothecin: current perspectives.

  2006cites this paper
• Medicinal Plants of Asia and the Pacific

  2006cites this paper
• Synthesis of benzo[c][1,8]phenanthrolin-6-one through cyclization of N-(isoquinol-5-yl)-2-bromo-benzamide derivatives

  2006cites this paper
• The tumor specific cytotoxicity of dihydronitidine from Toddalia asiatica Lam

  2006cites this paper
• Purification and characterization of a novel ATP-independent type I DNA topoisomerase from a marine methylotroph.

  2005cites this paper
• Direct, two-step synthetic pathway to novel dibenzo[a,c]phenanthridines.

  2005cites this paper
• AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex

  2004cites this paper
• Biological activities of pyridoacridines.

  2004cites this paper
• Synthesis and cytotoxic activity of benzo[c][1,7] and [1,8]phenanthrolines analogues of nitidine and fagaronine.

  2004cites this paper
• Recent advances in antineoplastic principles of Traditional Chinese Medicine.

  2002cites this paper
• A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin.

  2001cites this paper
• Structure‐Based Analysis of the Effects of Camptothecin on the Activities of Human Topoisomerase I

  2000cites this paper
• Molecular and Biological Determinants of the Cytotoxic Actions of Camptothecins: Perspective for the Development of New Topoisomerase I Inhibitors

  2000cites this paper